TD Asset Management’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
TCM
ACMC
MAP
O
VP
VCIM
TCM
TD Asset Management's SLRN Position: Q1 2025 in Review
TD Asset Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 267,656 shares — an estimated $840K sold.
TD Asset Management first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $1.29M in Q2 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.
- TD Asset Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
- TD Asset Management sold 267,656 ACELYRIN shares in Q1 2025, an estimated $840K.
- TD Asset Management first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
- TD Asset Management's ACELYRIN position peaked at $1.29M in Q2 2023.
- 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.
Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.